| A pan-cancer proteomic perspective on The Cancer Genome Atlas R Akbani, PKS Ng, HMJ Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, ... Nature communications 5 (1), 3887, 2014 | 556 | 2014 |
| The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers L Han, L Diao, S Yu, X Xu, J Li, R Zhang, Y Yang, HMJ Werner, ... Cancer cell 28 (4), 515-528, 2015 | 483 | 2015 |
| Identification of nine new susceptibility loci for endometrial cancer TA O’mara, DM Glubb, F Amant, D Annibali, K Ashton, J Attia, PL Auer, ... Nature communications 9 (1), 3166, 2018 | 212 | 2018 |
| The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, ... Nature genetics 48 (8), 848-855, 2016 | 200 | 2016 |
| Cancer systems biology: a peek into the future of patient care? HMJ Werner, GB Mills, PT Ram Nature reviews Clinical oncology 11 (3), 167-176, 2014 | 200 | 2014 |
| Lack of estrogen receptor-α is associated with epithelial–mesenchymal transition and PI3K alterations in endometrial carcinoma E Wik, MB Ræder, C Krakstad, J Trovik, E Birkeland, EA Hoivik, S Mjos, ... Clinical Cancer Research 19 (5), 1094-1105, 2013 | 170 | 2013 |
| Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial J Trovik, E Wik, HMJ Werner, C Krakstad, H Helland, I Vandenput, ... European journal of cancer 49 (16), 3431-3441, 2013 | 162 | 2013 |
| Preoperative tumor texture analysis on MRI predicts high‐risk disease and reduced survival in endometrial cancer S Ytre‐Hauge, JA Dybvik, A Lundervold, ØO Salvesen, C Krakstad, ... Journal of Magnetic Resonance Imaging 48 (6), 1637-1647, 2018 | 110 | 2018 |
| What is the role of imaging at primary diagnostic work-up in uterine cervical cancer? IS Haldorsen, N Lura, J Blaakær, D Fischerova, HMJ Werner Current oncology reports 21, 1-15, 2019 | 103 | 2019 |
| KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer E Birkeland, E Wik, S Mjøs, EA Hoivik, J Trovik, HMJ Werner, ... British journal of cancer 107 (12), 1997-2004, 2012 | 100 | 2012 |
| Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions IL Tangen, HMJ Werner, A Berg, MK Halle, K Kusonmano, J Trovik, ... European journal of cancer 50 (17), 3003-3010, 2014 | 93 | 2014 |
| Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification HMJ Werner, J Trovik, J Marcickiewicz, S Tingulstad, AC Staff, F Amant, ... Gynecologic oncology 125 (1), 103-108, 2012 | 93 | 2012 |
| Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers MB Raeder, E Birkeland, J Trovik, C Krakstad, S Shehata, S Schumacher, ... PloS one 8 (2), e54873, 2013 | 91 | 2013 |
| Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas TS Njølstad, H Engerud, HMJ Werner, HB Salvesen, J Trovik Gynecologic oncology 131 (2), 410-415, 2013 | 87 | 2013 |
| Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer HJ Mackay, EA Eisenhauer, S Kamel‐Reid, M Tsao, B Clarke, ... Cancer 120 (4), 603-610, 2014 | 86 | 2014 |
| ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas HMJ Werner, A Berg, E Wik, E Birkeland, C Krakstad, K Kusonmano, ... Modern Pathology 26 (3), 428-434, 2013 | 82 | 2013 |
| Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist: hip ratio, is causal for endometrial cancer JN Painter, TA O'Mara, L Marquart, PM Webb, J Attia, SE Medland, ... Cancer epidemiology, biomarkers & prevention 25 (11), 1503-1510, 2016 | 81 | 2016 |
| Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas S Ytre-Hauge, JA Husby, IJ Magnussen, HMJ Werner, ØO Salvesen, ... International Journal of Gynecologic Cancer 25 (3), 2015 | 79 | 2015 |
| Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome C Krakstad, J Trovik, E Wik, IB Engelsen, HMJ Werner, E Birkeland, ... British journal of cancer 106 (10), 1682-1688, 2012 | 76 | 2012 |
| Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses JN Painter, TA O'mara, AP Morris, THT Cheng, M Gorman, L Martin, ... Cancer medicine 7 (5), 1978-1987, 2018 | 73 | 2018 |
